Stock Analysis of Graphite Bio Inc (GRPH) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code GRPH
Close 50.00
Change 27.74 / 124.62 %
Volume 20800.00
Vol Change -26108.00 / 55.66 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bullish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index No Significant Stability


Fundamental View of Graphite Bio Inc
PE (TTM)

-1606.26

Very Poor
Price / Book

862.41

Very Poor
Price / Sales

19955.36

Very Poor
Piotroski F Score

3.0

Not Good
Market Cap

2911.84 M

Enterprise Value

2727.87 M

ROA (TTM)

-46.29

Very Poor
ROE (TTM)

-53.69

Very Poor
Net Margin (TTM)

-1242.35

Very Poor
Revenue

%

0
Net Profit

25.02 %

-126332.00 K
Debt to Equity

0.0016

Excellent
Altman Z Score

354.69

Excellent
Quick Ratio

0

Poor
Cash Ratio

38.41

Excellent


Highs/Lows of Graphite Bio Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week23.38 113.86 % 1.58 % 50.017.9922-Mar-2419-Mar-24
Two Week21.98 127.48 % 2.92 % 50.017.9922-Mar-2419-Mar-24
One Month21.21 135.74 % 3.52 % 50.017.9922-Mar-2419-Mar-24
Three Month16.73 198.86 % 5.46 % 50.016.7322-Mar-2426-Dec-23
Six Months16.66 200.12 % 15.09 % 50.014.070722-Mar-2415-Nov-23
One year16.38 205.25 % 24.22 % 50.014.070722-Mar-2415-Nov-23
Two year43.12 15.96 % 45.41 % 50.011.1322-Mar-2406-Jan-23


Technical View of Graphite Bio Inc
RSI

85.21

Mild Bearish
MACD

2.65

Mild Bullish
ADX

22.88

Mild Bullish
Super Trend

35.33

Mild Bullish
Williams %R

0

Mild Bearish
CCI

586.57

Mild Bearish


EMA 5

31.76

Neutral
EMA 15

26.21

Whipsaw
EMA 50

22.40

Strong Bullish
EMA 100

20.50

Strong Bullish
SMA 100

19.24

Strong Bullish
SMA 200

18.46

Strong Bullish
SMA 5 / 20

27.85 / 24.32

Neutral
SMA 15 / 50

25.02 / 21.79

Strong Bullish
SMA 50 / 200

21.79 / 18.46

Bullish




Charts of Graphite Bio Inc


Returns of Graphite Bio Inc with Peers
Period / StockGRPHIRTCTNDMACLX
1 Week113.86%-1.39%-7.21%7.15%
1 Mth135.74%-5.11%2.86%7.49%
3 Mth198.86%-10.13%61.89%-21.79%
6mth200.12%-8.08%66.96%6.06%
1 Year205.25%-8.02%71.19%43.41%
2 Year15.96%-17.20%-16.76%204.14%
5 Years-19.92%-28.70%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Graphite Bio Inc with Peers
Ratio / StockGRPHIRTCTNDMACLX
PE-1606.26-22.29-20.90-38679.10
P/B862.4115.009.605331.24
ROA-46.29-24.67-14.94-7.34
ROE-53.69-67.28-45.97-13.78
Debt To Equity0.00160.2390.9630.096
Revenue0
% 		472787 K
15.06 % 		771423 K
3.72 % 		47171.00 K
163.35 %
Net Income-126332.00 K
25.02 % 		-104905.00 K
9.69 % 		-208462.00 K
120.38 % 		-129526.00 K
31.35 %


Technicals of Graphite Bio Inc with Peers
Technical / StockGRPHIRTCTNDMACLX-
ADX22.8826.2932.2919.94
CMF-0.0950.063-0.105-0.0175
MFI73.1558.3838.5562.10
RSI85.2149.1444.3653.26
MACD Abv SignalTrueTrueFalseTrue
Price Above 50 MATrueFalseTrueTrue-
Price Above 200 MATrueFalseTrueTrue-


About : Graphite Bio Inc

Address : 611 Gateway Boulevard, South San Francisco, CA, United States, 94080
Tel : 650 484 0886
URL : https://graphitebio.com
Code : GRPH, ISIN : US38870X1046, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 25_Jun_2021
Employee Count : 6

As of March 21, 2024, Graphite Bio, Inc. was acquired by LENZ Therapeutics, Inc., in a reverse merger transaction. Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. The company offers GPH102 for the treatment of beta-thalassemia; and GPH201 for the treatment of XSCID, a life-threatening disease for multiple mutations in a single gene. It also offers GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is based in South San Francisco, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)